H. Lurie

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers

A. Sulkes, B. Brenner, E. Fenig, 2002, British Journal of Cancer.

Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.

E. Fenig, T. Umiel, T. Klein, 1989, Journal of biological response modifiers.

The Use of Cyclophosphamide, Methotrexate, and 5‐Fluorouracil in the Treatment of Merkel Cell Carcinoma

A. Sulkes, E. Fenig, H. Lurie, 1993, American journal of clinical oncology.

The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach.

A. Sulkes, E. Fenig, B. Klein, 1993, The Journal of dermatologic surgery and oncology.

Primary Squamous Cell Carcinoma (SqCC) of the Breast

H. Gutman, J. Schachter, T. Menes, 2003, American journal of clinical oncology.

Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects.

C. Servadio, J. Shaham, G. Gillon, 1987, Journal of biological response modifiers.

Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.

D. Lovén, A. Pick, H. Lurie, 1991, Acta oncologica.